Hormones in Cancer Development and Therapy

Certain cancers are driven by hormonal imbalances and receptor activity, including breast, prostate, and thyroid cancers. This session will delve into the mechanisms of hormone-driven carcinogenesis, early detection through molecular profiling, and hormone receptor modulation. Presentations will cover the use of endocrine therapies in cancer treatment and the promise of precision oncology. Experts will also explore survivorship issues and endocrine complications in cancer patients.

    Related Conference of Hormones in Cancer Development and Therapy

    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 27-28, 2025

    5th World Congress on Endocrine and Diabetes

    Madrid, Spain
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 03-04, 2025

    34th European Diabetes Congress

    Rome, Italy
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    November 24-25, 2025

    6th International conference on Diabetic complications

    Barcelona, Spain
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    September 23-24, 2026

    24th Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Aix-en-Provence, France

    Hormones in Cancer Development and Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in